Henrik Hallengreen Laustsen

Henrik Hallengreen Laustsen is an equity analyst at Jyske Bank, specializing in the pharmaceutical sector. He provides insights and analyses on market trends and company performances, including those of major players like Novo Nordisk. Recently, he expressed surprise at the announcement of Lars Fruergaard Jørgensen's resignation as CEO of Novo Nordisk, noting the potential impact on the company's stock and the uncertainty it may bring to investors amidst current market challenges.